Show simple item record

dc.rights.licenseopenen_US
dc.contributor.authorPUIGHERMANAL, Emma
dc.contributor.authorLUNA-SÁNCHEZ, Marta
dc.contributor.authorGELLA, Alejandro
dc.contributor.authorVAN DER WALT, Gunter
dc.contributor.authorURPI, Andrea
dc.contributor.authorROYO, María
dc.contributor.authorTENA-MORRAJA, Paula
dc.contributor.authorAPPIAH, Isabella
dc.contributor.authorDE DONATO, Maria Helena
dc.contributor.authorMENARDY, Fabien
dc.contributor.authorBIANCHI, Patrizia
dc.contributor.authorESTEVE-CODINA, Anna
dc.contributor.authorRODRÍGUEZ-PASCAU, Laura
dc.contributor.authorVERGARA, Cristina
dc.contributor.authorGÓMEZ-PALLARÈS, Mercè
hal.structure.identifierNeurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
dc.contributor.authorMARSICANO, Giovanni
hal.structure.identifierNeurocentre Magendie : Physiopathologie de la Plasticité Neuronale [U1215 Inserm - UB]
dc.contributor.authorBELLOCCHIO, Luigi
dc.contributor.authorMARTINELL, Marc
dc.contributor.authorSANZ, Elisenda
dc.contributor.authorJURADO, Sandra
dc.contributor.authorSORIANO, Francesc Xavier
dc.contributor.authorPIZCUETA, Pilar
dc.contributor.authorQUINTANA, Albert
dc.date.accessioned2025-05-19T14:01:16Z
dc.date.available2025-05-19T14:01:16Z
dc.date.issued2024-09-04
dc.identifier.issn2041-1723en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/206656
dc.description.abstractEnMutations in mitochondrial energy-producing genes lead to a heterogeneous group of untreatable disorders known as primary mitochondrial diseases (MD). Leigh syndrome (LS) is the most common pediatric MD and is characterized by progressive neuromuscular affectation and premature death. Here, we show that daily cannabidiol (CBD) administration significantly extends lifespan and ameliorates pathology in two LS mouse models, and improves cellular function in fibroblasts from LS patients. CBD delays motor decline and neurodegenerative signs, improves social deficits and breathing abnormalities, decreases thermally induced seizures, and improves neuropathology in affected brain regions. Mechanistically, we identify peroxisome proliferator-activated receptor gamma (PPARγ) as a key nuclear receptor mediating CBD’s beneficial effects, while also providing proof of dysregulated PPARγ expression and activity as a common feature in both mouse neurons and fibroblasts from LS patients. Taken together, our results provide the first evidence for CBD as a potential treatment for LS. © The Author(s) 2024.
dc.language.isoENen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.title.enCannabidiol ameliorates mitochondrial disease via PPARγ activation in preclinical models
dc.title.alternativeNat Communen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1038/s41467-024-51884-8en_US
dc.subject.halSciences du Vivant [q-bio]/Neurosciences [q-bio.NC]en_US
dc.identifier.pubmed39231983en_US
dc.description.sponsorshipEuropeElucidating Neuronal Susceptibility to Mitochondrial Diseaseen_US
bordeaux.journalNature Communicationsen_US
bordeaux.volume15en_US
bordeaux.hal.laboratoriesNeurocentre Magendie - U1215en_US
bordeaux.issue1en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamEndocannabinoïdes et Neuroadaptationen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-05073865
hal.version1
hal.date.transferred2025-05-19T14:01:22Z
hal.popularnonen_US
hal.audienceInternationaleen_US
hal.exporttrue
dc.rights.ccCC BY-NC-NDen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Nature%20Communications&rft.date=2024-09-04&rft.volume=15&rft.issue=1&rft.eissn=2041-1723&rft.issn=2041-1723&rft.au=PUIGHERMANAL,%20Emma&LUNA-S%C3%81NCHEZ,%20Marta&GELLA,%20Alejandro&VAN%20DER%20WALT,%20Gunter&URPI,%20Andrea&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record